Value investment firm Brandes Investment Partners, L.P., announced today that Charles Brandes, CFA, will present at the inaugural Asia Value Investor Conference in Hong Kong on December 8, 2015....

Today, AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced preliminary data from the ongoing Phase 1/2b PCYC-1119 trial suggesting that the combination of ibrutinib (IMBRUVICA®)...

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced an update on results from an investigator-sponsored Phase 2 trial of tosedostat – the company's investigational oral...

AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced results of a Phase 2, open label trial studying investigational compound venetoclax in patients with relapsed/refractory...

Data from the investigational, randomized, multi-center, open-label Phase 3 RESONATE™-2 (PCYC-1115) clinical trial show ibrutinib (IMBRUVICA®) was superior to chlorambucil in all efficacy...

Today, AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced the results of RESONATE™-2 (PCYC-1115), a Phase 3 clinical trial in which ibrutinib (IMBRUVICA®) significantly...

New, highly targeted treatment approaches for leukemia, lymphoma, and myeloma to be presented today at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition represent a...

Findings from an ongoing Phase IIa study to evaluate the safety and efficacy of investigational chimeric antigen receptor T cell (CART) therapy CTL019 in certain types of relapsed or refractory...

CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) and Baxalta Incorporated (Baxalta) (NYSE: BXLT) today announced results from a new analysis of the pivotal Phase 3 trial, PERSIST-1,...

Amgen (NASDAQ:AMGN) today announced the presentation of new key data evaluating Kyprolis® (carfilzomib) -based regimens in patients with relapsed multiple myeloma. The data showed Kyprolis in...

New research adds to a growing body of evidence that gene therapy, an experimental technique that involves correcting or replacing a person's mutated or malfunctioning genes, may improve health...

WHO: Andre Goy, M.D., M.S., Chairman, John Theurer Cancer Center and Chief, Division of Lymphoma, Hackensack University Medical Center; Andrew L. Pecora, MD, FACP, CPE, Vice President of Cancer...

CME Group announced today that John Pietrowicz, Chief Financial Officer, and Sean Tully, Senior Managing Director, Financial and OTC Products, will present at the Goldman Sachs U.S. Financial...

CHICAGO (December 4, 2015) - Jennifer Jackson, MBA, CCE, has been named the recipient of the 2015 ACCE-HIMSS Excellence in Clinical Engineering and Information Technology Synergies Award, a joint...

The Washington Auto Show® announces the first “ART-of-Motion” exhibit, an avant-garde design experience that befits the culture of Washington, D.C., as it hosts a tier-one show on the global...

Apartment List is proud to announce its third annual SPARK Conference, being held June 14-15, 2016 in San Francisco, California. SPARK is an invitation-only conference for thought leaders in the...

Bill Barrett Corporation (the "Company") (NYSE: BBG) announced today that it is scheduled to present at the Wells Fargo Energy Symposium at 11:00 a.m. ET (9:00 a.m. MT) on Wednesday, December 9, 2015.

Magellan Midstream Partners, L.P. (NYSE: MMP) announced today that Michael Mears, president and chief executive officer, is scheduled to present at the Wells Fargo Annual Energy Symposium at 8:35...

WHAT: Introduction to "Living" Drugs and the Curative Industries WHEN: 9:30 – 10:30 a.m. EST on Thursday, Dec. 10, 2015 WHERE: The 2015 World Stem Cell Summit - RegMed Capital Conference at the...

The 12th China International Self-service, Kiosk & Vending Show, held concurrently with iFair 2015, ran from Sep.16-18 at the Shanghai New International Expo Center, and turned out to be a great...

Trace3, a pioneer in digital business transformation, is pleased to announce that AppDynamics, a leading application intelligence company, recognized Trace3 as its "Top National Reseller" for 2015...

A coordinated push to decrypt a complex form of leukemia is delivering a trove of new drug candidates and treatment ideas, a dozen of which will be presented at the American Society of Hematology...

Sharp Imaging and Information Company of America (SIICA), a division of Sharp Electronics Corporation, is hosting its National Dealer Meeting from December 3 to 6, 2015 in San Antonio, TX. Themed...

Fran Shammo, executive vice president and chief financial officer of Verizon Communications Inc. (NYSE, Nasdaq: VZ), will speak at the UBS 43rd Annual Global Media and Communications Conference in...

Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced that it will present on its innovative nanoliposomal platform for patients with metastatic breast cancer at the 2015 San Antonio...